FC FRANCE SAS is a CDMO specialized in the development, manufacture, and packaging of veterinary products in the non-sterile oral form:
- Soluble oral powder (POS)
- Medicated Premix (PM)
- Liquid (solution/suspension)
- Dough
- Intraruminal device (BOLUS)
- Secondary packaging
Located 50 km from Paris in the Val d’Oise in Magny en Vexin, from July 2021, the site became FC France SAS, a subsidiary of Friulchem S.p.A. and Finest S.p.A.
Friulchem S.p.A. controls FC France SAS, a company listed on EGM Euronext Growth Milano since July 2019; Italian leader of CDMOs (Contract Development Manufacturing Organizations) for bulk and finished products containing active pharmaceutical ingredients and food supplements, specialized in Drug Delivery Systems dedicated to the animal health industry.
Disma Giovanni Mazzola, CEO of Friulchem Spa, presented his industrial offer to the SIMV directors who voted for his membership during the Board of Directors meeting on March 7, 2023.
For more information: www.fc-france.com